Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 19, 2012 00:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept Corporation Receives One-Month Extension to Loan and Security Agreement

TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that MidCap Financial, LLC...
September 25, 2012 00:26 ET | Source: Immune Pharmaceuticals Inc

EpiCept Corporation Raises $0.8 Million from Immediate Exercise of Re-priced Warrants

Series A and B Preferred Stock Conversion Prices Also Affected TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange...
September 05, 2012 00:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept Regains Rights to Azixa® from Licensee Myrexis

TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today it has received notice of...
August 31, 2012 00:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept Amends Loan and Security Agreement

TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that it has amended the...
August 30, 2012 00:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept Announces Changes to Its Board of Directors

TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that A. Collier Smyth, Gerhard...
August 21, 2012 17:45 ET | Source: Immune Pharmaceuticals Inc

EpiCept Announces Resignation of CEO Jack Talley

TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com))-- Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that Jack Talley has resigned as...
August 08, 2012 00:02 ET | Source: Immune Pharmaceuticals Inc

EpiCept Reports Second Quarter 2012 Operating and Financial Results

CONFERENCE CALL BEGINS AT 9:00 A.M. EASTERN TIME TODAY TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX:...
August 02, 2012 17:00 ET | Source: Immune Pharmaceuticals Inc

EpiCept to Report Second Quarter 2012 Operating and Financial Results on August 8, 2012

TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that it will host a conference...
June 19, 2012 00:02 ET | Source: Immune Pharmaceuticals Inc

EpiCept Transfers Ceplene Responsibilities in European Union and Sells License Rights to Meda

ONLY TERRITORY ALREADY LICENSED TO MEDA AFFECTED TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)...
June 12, 2012 17:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept Corporation to Present at 2012 BIO International Convention

2012 BIO International Convention TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)...